Tags » Bladder Cancer

I'm Way Up, I Feel Blessed


Having a stagnant life can lead to regular battles with overpowering self-pity, and I am not immune to them. I’ve said through this whole thing that I would not let cancer define me, change me or lessen my self-worth. 405 more words

Bladder Cancer

Heat Biologics, Inc. to Present at the 2015 American Association for Cancer Research Annual Meeting

DURHAM, N.C., April 22, 2015 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (Nasdaq:HTBX), a clinical stage biopharmaceutical company focused on the development of cancer immunotherapies, today announced details of its presentation providing an update on immune responder and non-responder phenotypes from the phase I clinical trial of HS-410 in bladder cancer. 398 more words

Preclinical & Clinical

Foundation Medicine and Collaborators to Present New Data in 12 Oral and Poster Presentations at the AACR Annual Meeting

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company and its collaborators will present 12 oral and poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2015 taking place April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. 1,069 more words

Scientific Conferences & Presentations

cCAM Biotherapeutics Announces Initiation of Phase 1 Trial of CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy

MISGAV, Israel–(BUSINESS WIRE)–cCAM Biotherapeutics, a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced today that the first patient was dosed in a Phase 1 clinical trial of CM-24, a first-in-class immunomodulatory monoclonal antibody (mAb) for the treatment of various types of cancers. 604 more words

Preclinical & Clinical

Second Opinions are the Name of the Game

Well it has been a while since I last wrote about George’s saga with his cancer.  But for now we are in a holding pattern going through the second and even third opinion stages.  649 more words

PsiOxus Therapeutics Expands Clinical Studies for Immuno-Oncolytic Treatment Following Positive Response to Intravenous Delivery

OXFORD, England–(BUSINESS WIRE)–PsiOxus Therapeutics Ltd. (PsiOxus), an Oxford, UK based biotechnology company developing innovative oncolytic immuno-oncology treatments for cancer, has expanded two of its on-going phase I studies using its anti-cancer treatment candidate, … 566 more words

Preclinical & Clinical

The "bitch" is back

So much has happened in the last 7 months.  Things were touch and go with dad.  He developed a bad infection on his foot.  When I took him to the hospital, the surgeon basically said that because of his age, and the fact that he has a heart condition, there was a very slim chance of him surviving the op.   783 more words